Application
ACN9 Antibody (N-term) western blot analysis in mouse bladder tissue lysates (35ug/lane).This demonstrates the ACN9 antibody detected the ACN9 protein (arrow).Application
ACN9 Antibody (N-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human hepatocarcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the ACN9 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Product Name | ACN9 Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | ACN9; Protein ACN9 homolog, mitochondrial |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | ACN9 Protein ACN9 homolog mitochondrial |
|---|---|
| Molecular Weight(MW) | 14652 Da |
| Tissue Specificity | This ACN9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 13-42 amino acids from the N-terminal region of human ACN9. |
| Cellular Localization | Mitochondrion (Potential). |
| Entrez Gene | 57001 |
|---|---|
| Nucleotide Accession | NP_064571.1 |
Application
ACN9 Antibody (N-term) western blot analysis in mouse bladder tissue lysates (35ug/lane).This demonstrates the ACN9 antibody detected the ACN9 protein (arrow).
Application
ACN9 Antibody (N-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human hepatocarcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the ACN9 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
